Chimerix Inc financial data

Symbol
CMRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2505 Meridian Parkway, Suite 100, Durham, NC
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 21, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 681 % -45.8%
Debt-to-equity 15.3 % +84.7%
Return On Equity -60.2 % -58.8%
Return On Assets -52.2 % -49.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 93.8M shares +4.66%
Common Stock, Shares, Outstanding 92.2M shares +3.69%
Entity Public Float 74.3M USD -20.6%
Weighted Average Number of Shares Outstanding, Basic 89.7M shares +1.24%
Weighted Average Number of Shares Outstanding, Diluted 89.7M shares +1.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 212K USD -34.6%
Cost of Revenue 0 USD -100%
General and Administrative Expense 22.2M USD -9.74%
Operating Income (Loss) -96.6M USD -3.76%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -24M USD -110%
Income Tax Expense (Benefit) 0 USD -100%
Net Income (Loss) Attributable to Parent -88.4M USD -7.66%
Earnings Per Share, Basic -0.99 USD/shares -6.45%
Earnings Per Share, Diluted -0.99 USD/shares -6.45%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 57K USD +1325%
Other Assets, Current 1.84M USD -36.3%
Assets, Current 136M USD -28.1%
Property, Plant and Equipment, Net 417K USD +86.2%
Operating Lease, Right-of-Use Asset 951K USD -35.8%
Other Assets, Noncurrent 214K USD -28.9%
Assets 146M USD -31.4%
Accounts Payable, Current 3.94M USD +38.1%
Accrued Liabilities, Current 19.9M USD +27.8%
Liabilities, Current 23.9M USD +29.4%
Operating Lease, Liability, Noncurrent 458K USD -61.1%
Liabilities 24.3M USD +23.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 23K USD +229%
Retained Earnings (Accumulated Deficit) -884M USD -11.1%
Stockholders' Equity Attributable to Parent 122M USD -37%
Liabilities and Equity 146M USD -31.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.5M USD +21.2%
Net Cash Provided by (Used in) Financing Activities 208K USD +4.52%
Net Cash Provided by (Used in) Investing Activities 8.68M USD -28.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 92.2M shares +3.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.64M USD +12.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31M USD +12.2%
Deferred Tax Assets, Valuation Allowance 178M USD +10.9%
Deferred Tax Assets, Gross 178M USD +10.8%
Operating Lease, Liability 1.18M USD -35.3%
Depreciation 22K USD 0%
Payments to Acquire Property, Plant, and Equipment 27K USD -56.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -88.4M USD -8.1%
Lessee, Operating Lease, Liability, to be Paid 1.25M USD -37.8%
Property, Plant and Equipment, Gross 5.39M USD +0.13%
Operating Lease, Liability, Current 719K USD +12%
Lessee, Operating Lease, Liability, to be Paid, Year Two 467K USD -40.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 781K USD +2.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 71K USD -62.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 467K USD -40.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 6.8M USD +10.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 467K USD 0%
Operating Lease, Payments 800K USD +14.3%
Additional Paid in Capital 1.01B USD +1.72%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 225K USD -36.1%
Share-based Payment Arrangement, Expense 9.48M USD -45.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%